Literature DB >> 11526265

Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number.

J H Lim1, D Choi, S K Cho, S H Kim, W J Lee, H K Lim, C K Park, S W Paik, Y I Kim.   

Abstract

PURPOSE: To correlate the conspicuity of hepatocellular carcinomas and dysplastic nodules on ferumoxides-enhanced magnetic resonance (MR) images with the number of Kupffer cells in the hepatic lesions, as compared with that in background liver in histopathologic findings.
MATERIALS AND METHODS: Sixty-nine histopathologically proved moderately or poorly differentiated hepatocellular carcinomas, 10 well-differentiated hepatocellular carcinomas, and 19 dysplastic nodules were retrospectively studied in 68 patients with cirrhosis who underwent ferumoxides-enhanced MR imaging. The contrast-to-noise ratio between the nodules and surrounding parenchyma was calculated at T2-weighted fast spin-echo imaging, and the difference in the number of Kupffer cells between the nodules and surrounding hepatic tissue was calculated histopathologically. The results of MR imaging and histopathologic examination were correlated.
RESULTS: All 69 moderately or poorly differentiated hepatocellular carcinomas had high contrast-to-noise ratios at MR imaging and large differences in the number of Kupffer cells. Six of the 10 well-differentiated hepatocellular carcinomas had contrast-to-noise ratios of zero or nearly zero, and five of these had little difference in the number of Kupffer cells. All 19 dysplastic nodules had contrast-to-noise ratios of zero or nearly zero, and there were virtually no differences in the number of Kupffer cells.
CONCLUSION: Hepatocellular nodule conspicuity at ferumoxides-enhanced MR imaging depends on differences in the number of Kupffer cells within a nodule and the surrounding cirrhotic liver; moderately or poorly differentiated hepatocellular carcinomas can be distinguished from well-differentiated hepatocellular carcinomas and dysplastic nodules.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526265     DOI: 10.1148/radiol.2203001777

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  20 in total

1.  Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI.

Authors:  C-T Chou; R-C Chen; W-T Chen; J-M Lii
Journal:  Br J Radiol       Date:  2010-04-22       Impact factor: 3.039

Review 2.  Magnetic resonance imaging of the cirrhotic liver: An update.

Authors:  Agnes Watanabe; Miguel Ramalho; Mamdoh AlObaidy; Hye Jin Kim; Fernanda G Velloni; Richard C Semelka
Journal:  World J Hepatol       Date:  2015-03-27

3.  Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging.

Authors:  Bronwyn E Hamilton; Gary M Nesbit; Edit Dosa; Seymur Gahramanov; Bill Rooney; Eric G Nesbit; Joshua Raines; Edward A Neuwelt
Journal:  AJR Am J Roentgenol       Date:  2011-10       Impact factor: 3.959

Review 4.  Superparamagnetic iron oxide-enhanced magnetic resonance imaging for focal hepatic lesions: systematic review and meta-analysis.

Authors:  You-Wei Li; Zheng-Guang Chen; Ji-Chen Wang; Zong-Ming Zhang
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

5.  Pathomorphological study on location and distribution of Kupffer cells in hepatocellular carcinoma.

Authors:  Kai Liu; Xu He; Xue-Zhong Lei; Lian-San Zhao; Hong Tang; Li Liu; Bing-Jun Lei
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

6.  MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers.

Authors:  L Macarini; P Milillo; A Cascavilla; G Scalzo; L Stoppino; R Vinci; G Moretti; G Ettorre
Journal:  Radiol Med       Date:  2009-11-09       Impact factor: 3.469

7.  Small hypervascular hepatocellular carcinomas: value of "washout" on gadolinium-enhanced dynamic MR imaging compared to superparamagnetic iron oxide-enhanced imaging.

Authors:  Jeong-Sik Yu; Jae-Joon Chung; Joo Hee Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2009-06-10       Impact factor: 5.315

8.  Small (<or=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT.

Authors:  R Golfieri; E Marini; A Bazzocchi; F Fusco; F Trevisani; C Sama; G Mazzella; S Cavuto; F Piscaglia; L Bolondi
Journal:  Radiol Med       Date:  2009-08-20       Impact factor: 3.469

9.  SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings.

Authors:  Seong Hyun Kim; Won Jae Lee; Hyo K Lim; Cheol Keun Park
Journal:  Korean J Radiol       Date:  2009-03-03       Impact factor: 3.500

10.  Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences.

Authors:  Seung Hoon Kim; Dongil Choi; Jae Hoon Lim; Won Jae Lee; Hyun Jung Jang; Hyo Keun Lim; Soon Jin Lee; Jae Min Cho; Seung Kwon Kim; Gab Chul Kim
Journal:  Korean J Radiol       Date:  2002 Apr-Jun       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.